Treatment strategy for mucus-producing bronchioloalveolar epithelial cancer
Project/Area Number |
15K10265
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Respiratory surgery
|
Research Institution | Oita University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
宮脇 美千代 大分大学, 医学部, 講師 (30404388)
杉尾 賢二 大分大学, 医学部, 教授 (70235927)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2015: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 粘液産生性細気管支肺胞上皮癌 / targeted resequencing / primary culture / cell cycle / energy metabolism / 浸潤性粘液産生性腺癌 |
Outline of Final Research Achievements |
Genomic DNA was extracted for 13 cases of mucin-producing bronchioloalveolar epithelial cancer (invasive mucinous adenocarcinoma, IMA in the new WHO classification) in which paraffin-embedded sections are available, and targeted resequencing by Ion AmpliSeq Cancer Hotspot Panel v 2 I made Thing. Among 13 cases, 10 cases were analyzable. As gene mutation, 4 cases of K-ras mutation, 3 cases of TP53 mutation, others, LKB1 mutation, PIK3CA mutation, EGFR mutation, ATM mutation were confirmed in each case.
|
Report
(4 results)
Research Products
(59 results)
-
-
-
-
-
[Journal Article] Pemetrexed-induced scleroderma-like conditions in the lower legs of a patient with non-small cell lung carcinoma.2016
Author(s)
Ishikawa K, Sakai T, Saito- Shono T, Miyawaki M, Osoegawa A, Sugio K, Ono A, Mori H, Nishida H, Yokoyama S, Okamoto O, Fujiwara S, Hatano Y
-
Journal Title
J Dermatol
Volume: -
Issue: 9
Pages: 1071-1074
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Mutations of the EGFR, K-ras, EML4-ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma.2015
Author(s)
Ohba T, Toyokawa G, Osoegawa A, Hirai F, Yamaguchi M, Taguchi K, Seto T, Takenoyama M, Ichinose Y, Sugio K
-
Journal Title
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-